abstract |
The present invention relates to certain substituted quinuclidine-3-one compounds for use in the treatment of hyperproliferative diseases such as cancer and diseases associated with inflammation. More specifically, the present invention relates to certain substituted 3-quinuclidinones, pharmaceutically acceptable salts thereof, pharmaceutical compositions containing them, and methods for using such compounds. In this way, these compounds can be used to treat hyperproliferative and inflammatory diseases. |